From cell counts to cellular interactions: Cu-Cyto and the co-localization index as a spatial framework for the tumor immune microenvironment of rectal cancer
The tumor immune microenvironment in colorectal cancer has emerged as a major determinant of patient outcome, with tumor-infiltrating lymphocytes, particularly CD8⁺ T cells, mediating antitumor immunity. Standardized density-based metrics such as the Immunoscore have demonstrated prognostic value but cannot capture the spatial interactions among cells that underlie immune-tumor biology. We introduce a deep learning framework that integrates two complementary axes of analysis: Cu-Cyto, a deep learning-based image cytometry platform that detects and classifies approximately twenty cell types from standard immunohistochemistry-stained whole-slide images, using a bit-pattern kernel-filtering algorithm to prevent multi-counting and an off-target labeling strategy for precise nuclear-center localization; and the Co-Localization Index, which converts the classification probabilities and coordinates produced by Cu-Cyto into a single quantitative measure of co-localization between two or three cell types. We illustrate this framework through CD103⁺CD8⁺ tissue-resident memory-like T cells in rectal cancer treated with neoadjuvant chemoradiotherapy: their stromal but not intratumoral density independently predicts relapse-free survival. This divergence, which compartment-aware density alone cannot explain, motivates a metric that captures within-compartment spatial relationships. The Co-Localization Index extends naturally to three-cell interactions, providing a quantitative readout of the tri-cellular biology among CD103⁺CD8⁺ T cells, tumor cells, and stromal components. Prospective validation in independent rectal-cancer cohorts, addressing watch-and-wait organ preservation and adjuvant chemotherapy decisions, will determine whether this spatial-cellular framework translates into routine clinical decision support with potential extension to other solid tumor contexts.
Authors
- Shingo Kanaji (ORCID: https://orcid.org/0000-0002-8698-8923)
- Kimihiro Yamashita (ORCID: https://orcid.org/0000-0002-4208-7138)
- Yasunori Otowa (ORCID: https://orcid.org/0000-0001-8421-7343)
- Yoshihiro Kakeji (ORCID: https://orcid.org/0000-0002-2727-0241)
- Ryohei Sasaki (ORCID: https://orcid.org/0000-0002-4994-9386)
- Naoki Urakawa (ORCID: https://orcid.org/0000-0002-9154-4972)
- Mitsugu Fujita (ORCID: https://orcid.org/0000-0002-0000-9879)
- Yuna Asano
- Hiroki Kagiyama
- Takao Tsuneki (ORCID: https://orcid.org/0000-0002-4006-8267)
- Kumiko Miyashita
- Toru Takahashi (ORCID: https://orcid.org/0000-0003-2665-3520)
- Hironobu Goto (ORCID: https://orcid.org/0000-0002-4337-5529)
- Tomoki Abe (ORCID: https://orcid.org/0000-0001-8336-2223)
- Yukari Adachi
- Takaaki Tachibana
- Hiroshi Hasegawa
- Takeru Matsuda
- Masayuki Ando
- Masaki Imai
- Ryota Ito
- Takumi Fukumoto
- Toru Nagasaka
Institutions
- Hyogo University of Health Sciences (JP)
- Kobe University Hospital (JP)
- Sakai Municipal Hospital (JP)
- Hyogo Prefectural Cancer Center (JP)
- Kobe University (JP)
- Kindai University (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2026-09-08
- DOI
- https://doi.org/10.1007/s10147-026-03182-0
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kobe University
- Japan Society for the Promotion of Science